ADHD - Treatment Options and Consequences of Neglect
Authors:
- Klara WojciechowskaKWKlara Wojciechowska
- Monika TurekMTMonika Turek
- Aleksandra JarońAJAleksandra Jaroń
- Katarzyna JastrzębskaKJKatarzyna Jastrzębska
- Maria WitkowskaMWMaria Witkowska
- Joanna SkotnickaJSJoanna Skotnicka
- Karolina BłaszczakKBKarolina Błaszczak
- Adrian BorkowskiABAdrian Borkowski
- Mateusz SawickiMSMateusz Sawicki
Open Access
- 2 August 2024
- journal article
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 17, 53428
Abstract
Purpose of Research: Attention Deficit Hyperactivity Disorder (ADHD) is one of the most frequently diagnosed neurodevelopmental disorders. It is estimated to occur in approximately 5-10% of children and adolescents. This paper aims to highlight the challenges faced by individuals suffering from ADHD, present risk factors, summarize current treatment methods, and outline the consequences of neglecting treatment. Methods: Databases such as PubMed, Medline, and ResearchGate were used. Basic Results: The goal of ADHD treatment is to reduce the severity of symptoms and improve the social, academic, and emotional functioning of children and adolescents. The choice of treatment and the selection of a specific medication depend on the patient's age and coexisting disorders. Conclusions: ADHD often coexists with other mental disorders, complicating diagnosis and treatment. Lack of or ineffective treatment has consequences such as learning difficulties, disruptions in peer and family relationships. It correlates with higher rates of traffic accidents, accidental injuries, earlier onset, and higher rates of substance abuse.Keywords
This publication has 25 references indexed in Scilit:
- A systematic review of the beneficial effects of prebiotics, probiotics, and synbiotics on ADHDNeuropsychopharmacology Reports, 2024
- Nonstimulant Medications for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults: Systematic Review and Meta-analysisCNS Drugs, 2023
- Nonstimulant Treatments for ADHDChild and Adolescent Psychiatric Clinics of North America, 2022
- New Drugs to Treat ADHD: Opportunities and Challenges in Research and Development2022
- Current Pharmacological Treatments for ADHD2022
- The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorderNeuroscience & Biobehavioral Reviews, 2021
- A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age ChildrenClinical Therapeutics, 2020
- Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 yearsCochrane Database of Systematic Reviews, 2019
- Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disordersPharmacology Biochemistry and Behavior, 2011
- The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adultsClinical Therapeutics, 2009